Induced pluripotent stem cells: production and utility in regenerative medicine
Thursday, October 07, 2010 9:00 am - 5:00 pm
BioPark Hertfordshire
Broadwater Road
Welwyn Garden City, Hertfordshire AL7 3AX
United Kingdom
"The production of iPS cells from dermal fibroblasts has generated intense interest in the utility of such cells for research purposes and clinical applications. iPS cell production currently requires the use of transcription factor gene delivery to reprogramme cells into iPS cells. Hence, both gene delivery technology and iPS cell characterization and subsequent cell differentiation are critical aspects of iPS cell biology. This meeting will address both issues" Meeting Chairs: Professor Andrew Baker, University of Glasgow¸Scotland and Dr Chris Denning, University of Nottingham¸UK
The agenda for this event is under construction. If you have any queries or are interested in speaking at this event please contact meetingsproducer@euroscicon.com
This meeting has CPD approval
Confirmed Speakers
Dr Chris Denning, University of Nottingham¸UK
Confirmed Talks
Derivation of induced pluripotent cells from adult dermal fibroblasts in patients with CVD and controls.
Dr Nicole Kane, University of Glasgow¸Scotland
About the Chairs
Professor Andrew Baker graduated from the University of London in 1990 with a First Class BSc (Joint Honours) in pharmacology and toxicology and then studied for his PhD with the Leukaemia Research Fund at the University of Wales College of Medicine, graduating in 1994. He then joined the group led by Professor Andrew Newby for his post-doctoral work in Cardiff and developed adenoviral vectors for gene delivery studies in the cardiovascular system. This was at the very early stages of gene therapy. Dr. Baker then transferred to a lectureship at the University of Bristol (Bristol Heart Institute) to continue studies on adenovirus-mediated gene transfer to assess vascular function in different model systems. At the same time he initiated his independent research programmes focusing on how to engineer delivery systems for optimal use in vivo in gene therapy applications. In 1999, Dr. Baker joined Professor Anna Dominiczak’s group at the University of Glasgow as a Senior Lecturer in Molecular Medicine, then as Reader and now as Professor of Molecular Medicine. He is based at the British Heart Foundation Glasgow Cardiovascular Research Centre (BHF GCRC), which is a translational centre of excellence with a focus on primary and secondary prevention at cardiovascular disease.
|
For enquiries regarding payment email: sarah.edwards@euroscicon.com
You can pay by - Credit card, Cheque, Purchase Order or Bank transfer.
Payment must be received prior to the meeting
Credit card
Our preferred method of payment is during your online registration using your credit card. The information taken will be by secure server and we use world pay for our credit card transactions. We do not accept debit cards or American Express. Using this mode of payment you can guarantee that your fee has reached us prior to the conference and you will be listed as registered
Cheque Payment
Cheques should be made payable to Euroscicon and mailed (together with a print out of the invoice which will be available at the end of the registration process) to
Sarah Edwards
Euroscicon
BioPark Hertfordshire
Broadwater Road
Welwyn Garden City,
Hertfordshire AL7 3AX
United Kingdom
Purchase Order
Please input your Purchase Order number in the box provided once you have selected your mode of payment and an invoice will be sent to you accordingly
Bank transfer
Clients organizing bank transfers from non-UK banks will need to pay an additional administration fee of £15.00. Please ensure that you add this fee onto your payment to ensure successful registration
Please contact Sarah Edwards either by email (sarah.edwards@euroscicon.com) or by Fax ( 44) 07092114307 for our bank details
|